The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Neuroprotection for treatment of glaucoma in adults
|
|---|---|
| Published by |
John Wiley & Sons, Ltd, February 2013
|
| DOI | 10.1002/14651858.cd006539.pub3 |
| Pubmed ID | |
| Authors |
Sena, Dayse F, Lindsley, Kristina |
| Abstract |
Glaucoma is a heterogeneous group of conditions involving progressive damage to the optic nerve, deterioration of retinal ganglion cells and ultimately visual field loss. It is a leading cause of blindness worldwide. Open angle glaucoma (OAG), the commonest form of glaucoma, is a chronic condition that may or may not present with increased intraocular pressure (IOP). Neuroprotection for glaucoma refers to any intervention intended to prevent optic nerve damage or cell death. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 109 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 23 | 21% |
| Other | 15 | 14% |
| Student > Ph. D. Student | 15 | 14% |
| Student > Master | 14 | 13% |
| Student > Doctoral Student | 11 | 10% |
| Other | 26 | 23% |
| Unknown | 7 | 6% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 57 | 51% |
| Agricultural and Biological Sciences | 12 | 11% |
| Biochemistry, Genetics and Molecular Biology | 6 | 5% |
| Nursing and Health Professions | 4 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Other | 16 | 14% |
| Unknown | 12 | 11% |